Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with Biosero, a developer of laboratory automation solutions, to enable and facilitate robotic arm ...
After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest ...
today announced a framework collaboration agreement to enable and facilitate robotic arm integration with BD flow cytometry instruments to accelerate drug discovery and development. Together ...
and BD FACSLyricTM Flow Cytometry System will be available for research use in 2025 through local sales representatives. The BD FACSDiscoverTM family of instruments is also on the roadmap for ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, today ...